Top Markets
#1 DogBull DogBull +26.14%
#2 Merlin's Seal BTC Merlin's Seal BTC +25.80%
#3 Siacoin Siacoin +19.58%
#4 Cash Cat Cash Cat +15.36%
#5 0G 0G +8.55%
#6 Akedo Akedo +8.33%
#7 The Bitcoin Bull The Bitcoin Bull +8.31%
#8 Asteroid Shiba Asteroid Shiba +7.36%
#9 The Black Bull The Black Bull +6.52%
#10 MANTRA MANTRA +6.42%
Coin of the day
DogBull DogBull
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Valerio Therapeutics S.A. Valerio Therapeutics S.A.

Valerio Therapeutics S.A.

ALVIO
Rang in aandelen #14060
Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A.... Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A. (known as Onxeo SA until June 2023) is a clinical-stage biotechnology company dedicated to the global research and development of oncology treatments. Their focus is on targeting the DNA repair processes crucial for tumor survival. The company's offerings include Beleodaq, an approved medication for peripheral T-cell lymphoma. Their development pipeline features AsiDNA, which is progressing through Phase 1 clinical trials for metastatic melanoma and is also being evaluated for relapsed ovarian cancer through a research collaboration with Gustave Roussy. Furthermore, Valerio Therapeutics is advancing OX401, a preclinical program targeting DNA damage response and immuno-oncology, along with its proprietary platON decoy oligonucleotide platform. The firm also holds a licensing agreement with Acrotech Biopharma LLC.
Aandeelprijs
$0.88012714
Laatst gesynchroniseerd: 2026-08-31
Marktkapitalisatie
$439.58M
Verandering (1 dag)
-4.01%
Verandering (1 jaar)
1,131.97%
Land
FR
Handel Valerio Therapeutics S.A. (ALVIO)

Categorie

Healthcare
Winst voor Valerio Therapeutics S.A. (ALVIO)
Winst in 2026 TTM: 0
Volgens de meest recente financiële verslagen van Valerio Therapeutics S.A. bedraagt de huidige winst van het bedrijf 0. In 2026 behaalde het bedrijf een winst van 0, gelijk aan de winst van 2026, die 0 bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Valerio Therapeutics S.A. van 2026 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH